1. Compston JE, McClung MR, Leslie WD: Osteoporosis. Lancet 2019, 393(10169):364-376.
2. J. Z, E. D, D. P-A: Osteoporosis epidemiology using international cohorts. Curr Opin Rheumatol 2020, 32(4).
3. Schousboe JT: Epidemiology of Vertebral Fractures. J Clin Densitom 2016, 19(1):8-22.
4. Chen Y, Li YQ, Fang JY, Li P, Li F: Establishment of the concurrent experimental model of osteoporosis combined with Alzheimer's disease in rat and the dual-effects of echinacoside and acteoside from Cistanche tubulosa. J Ethnopharmacol 2020, 257:112834.
5. Zhai X, Yan Z, Zhao J, Chen K, Yang Y, Cai M, He C, Huang C, Li B, Yang M et al: Muscone Ameliorates Ovariectomy-Induced Bone Loss and Receptor Activator of Nuclear Factor-kappab Ligand-Induced Osteoclastogenesis by Suppressing TNF Receptor-Associated Factor 6-Mediated Signaling Pathways. Front Pharmacol 2020, 11:348.
6. Tang XY, Gao MX, Xiao HH, Yun WJ, Dai Y, Yao ZH, Wong MS, Yao XS: Simultaneous Quantitative Analysis of Multiple Biotransformation Products of Xian-Ling-Gu-Bao, a Traditional Chinese Medicine Prescription, with Rat Intestinal Microflora by Ultra-Performance Liquid Chromatography Tandem Triple Quadrupole Mass Spectrometry. J Chromatogr Sci 2020.
7. Shehzad O, Kim HP, Kim YS: State-of-the-art separation of ginsenosides from Korean white and red ginseng by countercurrent chromatography. Anal Bioanal Chem 2013, 405(13):4523-4530.
8. Zhou W, Huang H, Zhu H, Zhou P, Shi X: New metabolites from the biotransformation of ginsenoside Rb1 by Paecilomyces bainier sp.229 and activities in inducing osteogenic differentiation by Wnt/beta-catenin signaling activation. J Ginseng Res 2018, 42(2):199-207.
9. Song M, Jia F, Cao Z, Zhang H, Liu M, Gao L: Ginsenoside Rg3 Attenuates Aluminum-Induced Osteoporosis Through Regulation of Oxidative Stress and Bone Metabolism in Rats. Biol Trace Elem Res 2020.
10. Gao B, Huang Q, Jie Q, Zhang HY, Wang L, Guo YS, Sun Z, Wei BY, Han YH, Liu J et al: Ginsenoside-Rb2 inhibits dexamethasone-induced apoptosis through promotion of GPR120 induction in bone marrow-derived mesenchymal stem cells. Stem Cells Dev 2015, 24(6):781-790.
11. Ru J, Li P, Wang J, Zhou W, Li B, Huang C, Li P, Guo Z, Tao W, Yang Y et al: TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform 2014, 6:13.
12. Kar S, Leszczynski J: Recent Advances of Computational Modeling for Predicting Drug Metabolism: A Perspective. Curr Drug Metab 2017, 18(12):1106-1122.
13. Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z et al: DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res 2018, 46(D1):D1074-D1082.
14. Lu XJ: DSSR-enabled innovative schematics of 3D nucleic acid structures with PyMOL. Nucleic Acids Res 2020.
15. Reimand J, Isserlin R, Voisin V, Kucera M, Tannus-Lopes C, Rostamianfar A, Wadi L, Meyer M, Wong J, Xu C et al: Pathway enrichment analysis and visualization of omics data using g:Profiler, GSEA, Cytoscape and EnrichmentMap. Nat Protoc 2019, 14(2):482-517.
16. Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork P et al: STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res 2019, 47(D1):D607-D613.
17. Luo W, Pant G, Bhavnasi YK, Blanchard SG, Jr., Brouwer C: Pathview Web: user friendly pathway visualization and data integration. Nucleic Acids Res 2017, 45(W1):W501-W508.
18. Yu W, Clyne M, Khoury MJ, Gwinn M: Phenopedia and Genopedia: disease-centered and gene-centered views of the evolving knowledge of human genetic associations. Bioinformatics 2010, 26(1):145-146.
19. Pinero J, Ramirez-Anguita JM, Sauch-Pitarch J, Ronzano F, Centeno E, Sanz F, Furlong LI: The DisGeNET knowledge platform for disease genomics: 2019 update. Nucleic Acids Res 2020, 48(D1):D845-D855.
20. Bardou P, Mariette J, Escudie F, Djemiel C, Klopp C: jvenn: an interactive Venn diagram viewer. BMC Bioinformatics 2014, 15:293.
21. Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C, Chanda SK: Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun 2019, 10(1):1523.
22. Shen S, Kong J, Qiu Y, Yang X, Wang W, Yan L: Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis. J Cell Biochem 2019, 120(6):10069-10081.
23. Gore S, Sanz Garcia E, Hendrickx PMS, Gutmanas A, Westbrook JD, Yang H, Feng Z, Baskaran K, Berrisford JM, Hudson BP et al: Validation of Structures in the Protein Data Bank. Structure 2017, 25(12):1916-1927.
24. Bitencourt-Ferreira G, de Azevedo WF, Jr.: Docking with SwissDock. Methods Mol Biol 2019, 2053:189-202.
25. CC. H, EC. M, JH. M, EF. P, TE. F: Enhancing UCSF Chimera through web services. Nucleic Acids Res 2014, 42.
26. Xu XX, Bi JP, Ping L, Li P, Li F: A network pharmacology approach to determine the synergetic mechanisms of herb couple for treating rheumatic arthritis. Drug Des Devel Ther 2018, 12:967-979.
27. Chotiyarnwong P, McCloskey EV: Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment. Nat Rev Endocrinol 2020.
28. Schidlitzki A, Bascunana P, Srivastava PK, Welzel L, Twele F, Tollner K, Kaufer C, Gericke B, Feleke R, Meier M et al: Proof-of-concept that network pharmacology is effective to modify development of acquired temporal lobe epilepsy. Neurobiol Dis 2020, 134:104664.
29. Chen Y, Fan X: Use of Chou's 5-Steps Rule to Reveal Active Compound and Mechanism of Shuangshen Pingfei San on Idiopathic Pulmonary Fibrosis. Curr Mol Med 2020, 20(3):220-230.
30. Wen Y, Guo X, Hao J, Xiao X, Wang W, Wu C, Wang S, Yang T, Shen H, Chen X et al: Integrative analysis of genome-wide association studies and gene expression profiles identified candidate genes for osteoporosis in Kashin-Beck disease patients. Osteoporos Int 2016, 27(3):1041-1046.
31. Sun B, Sun J, Han X, Liu H, Li J, Du J, Feng W, Liu B, Cui J, Guo J et al: Immunolocalization of MMP 2, 9 and 13 in prednisolone induced osteoporosis in mice. Histol Histopathol 2016, 31(6):647-656.
32. Liu WJ, Jiang ZM, Chen Y, Xiao PT, Wang ZY, Huang TQ, Liu EH: Network pharmacology approach to elucidate possible action mechanisms of Sinomenii Caulis for treating osteoporosis. J Ethnopharmacol 2020, 257:112871.
33. Liu L, Yang XL, Zhang H, Zhang ZJ, Wei XT, Feng GJ, Liu J, Peng HP, Hai R, Shen H et al: Two novel pleiotropic loci associated with osteoporosis and abdominal obesity. Hum Genet 2020.
34. Kim YA, Choi HJ, Lee JY, Han BG, Shin CS, Cho NH: Replication of Caucasian loci associated with bone mineral density in Koreans. Osteoporos Int 2013, 24(10):2603-2610.
35. An Y, Zhang H, Wang C, Jiao F, Xu H, Wang X, Luan W, Ma F, Ni L, Tang X et al: Activation of ROS/MAPKs/NF-kappaB/NLRP3 and inhibition of efferocytosis in osteoclast-mediated diabetic osteoporosis. FASEB J 2019, 33(11):12515-12527.
36. Jin W, Zhu X, Yao F, Xu X, Chen X, Luo Z, Zhao D, Li X, Leng X, Sun L: Cytoprotective effect of Fufang Lurong Jiangu capsule against hydrogen peroxide-induced oxidative stress in bone marrow stromal cell-derived osteoblasts through the Nrf2/HO-1 signaling pathway. Biomed Pharmacother 2020, 121:109676.
37. Sun J, Yu X, Huangpu H, Yao F: Ginsenoside Rb3 protects cardiomyocytes against hypoxia/reoxygenation injury via activating the antioxidation signaling pathway of PERK/Nrf2/HMOX1. Biomed Pharmacother 2019, 109:254-261.
38. Yang L, Zhang B, Liu J, Dong Y, Li Y, Li N, Zhao X, Snooks H, Hu C, Ma X: Protective Effect of Acteoside on Ovariectomy-Induced Bone Loss in Mice. Int J Mol Sci 2019, 20(12).
39. Menendez-Gutierrez MP, Roszer T, Fuentes L, Nunez V, Escolano A, Redondo JM, De Clerck N, Metzger D, Valledor AF, Ricote M: Retinoid X receptors orchestrate osteoclast differentiation and postnatal bone remodeling. J Clin Invest 2015, 125(2):809-823.
40. Claro da Silva T, Hiller C, Gai Z, Kullak-Ublick GA: Vitamin D3 transactivates the zinc and manganese transporter SLC30A10 via the Vitamin D receptor. J Steroid Biochem Mol Biol 2016, 163:77-87.
41. Yang R, Chen J, Zhang J, Qin R, Wang R, Qiu Y, Mao Z, Goltzman D, Miao D: 1,25-Dihydroxyvitamin D protects against age-related osteoporosis by a novel VDR-Ezh2-p16 signal axis. Aging Cell 2020, 19(2):e13095.
42. Wu F, Zhou D, Shen G, Cui Y, Lv Q, Wei F: Association of VDR and OPG gene polymorphism with osteoporosis risk in Chinese postmenopausal women. Climacteric 2019, 22(2):208-212.
43. Ishii M, Kikuta J: Sphingosine-1-phosphate signaling controlling osteoclasts and bone homeostasis. Biochim Biophys Acta 2013, 1831(1):223-227.
44. Kim BJ, Koh JM: Coupling factors involved in preserving bone balance. Cell Mol Life Sci 2019, 76(7):1243-1253.
45. Brylka LJ, Schinke T: Chemokines in Physiological and Pathological Bone Remodeling. Front Immunol 2019, 10:2182.
46. Wojdasiewicz P, Turczyn P, Dobies-Krzesniak B, Frasunska J, Tarnacka B: Role of CX3CL1/CX3CR1 Signaling Axis Activity in Osteoporosis. Mediators Inflamm 2019, 2019:7570452.
47. Lertsuwan K, Nammultriputtar K, Nanthawuttiphan S, Tannop N, Teerapornpuntakit J, Thongbunchoo J, Charoenphandhu N: Differential effects of Fe2+ and Fe3+ on osteoblasts and the effects of 1,25(OH)2D3, deferiprone and extracellular calcium on osteoblast viability under iron-overloaded conditions. PLoS One 2020, 15(5):e0234009.
48. Cui J, Li X, Wang S, Su Y, Chen X, Cao L, Zhi X, Qiu Z, Wang Y, Jiang H et al: Triptolide prevents bone loss via suppressing osteoclastogenesis through inhibiting PI3K-AKT-NFATc1 pathway. J Cell Mol Med 2020.
49. Manandhar S, Kabekkodu SP, Pai KSR: Aberrant canonical Wnt signaling: Phytochemical based modulation. Phytomedicine 2020, 76:153243.
50. Mahendra CK, Tan LTH, Lee WL, Yap WH, Pusparajah P, Low LE, Tang SY, Chan KG, Lee LH, Goh BH: Angelicin-A Furocoumarin Compound With Vast Biological Potential. Front Pharmacol 2020, 11:366.
51. Cui J, Li X, Wang S, Su Y, Chen X, Cao L, Zhi X, Qiu Z, Wang Y, Jiang H et al: Triptolide prevents bone loss via suppressing osteoclastogenesis through inhibiting PI3K-AKT-NFATc1 pathway. J Cell Mol Med 2020, 24(11):6149-6161.
52. Yu T, Wu Q, You X, Zhou H, Xu S, He W, Li Z, Li B, Xia J, Zhu H et al: Tomatidine Alleviates Osteoporosis by Downregulation of p53. Med Sci Monit 2020, 26:e923996.
53. You L, Chen L, Pan L, Peng Y, Chen J: SOST Gene Inhibits Osteogenesis from Adipose-Derived Mesenchymal Stem Cells by Inducing Th17 Cell Differentiation. Cell Physiol Biochem 2018, 48(3):1030-1040.
54. Yu L, Wang X, Gao X, Tong J, Zhang J: The calcium transient characteristics induced by fluid shear stress affect the osteoblast proliferation. Exp Cell Res 2018, 362(1):51-62.
55. Sternberg Z: Cardiovascular Autonomic Dysfunction: Link Between Multiple Sclerosis Osteoporosis and Neurodegeneration. Neuromolecular Med 2018, 20(1):37-53.
56. Weske S, Vaidya M, Reese A, von Wnuck Lipinski K, Keul P, Bayer JK, Fischer JW, Flogel U, Nelsen J, Epple M et al: Targeting sphingosine-1-phosphate lyase as an anabolic therapy for bone loss. Nat Med 2018, 24(5):667-678.
57. Zhang Y, Yang K, Yang J, Lao Y, Deng L, Deng G, Yi J, Sun X, Wang Q: SENP3 Suppresses Osteoclastogenesis by De-conjugating SUMO2/3 from IRF8 in Bone Marrow-Derived Monocytes. Cell Rep 2020, 30(6):1951-1963 e1954.
58. Aouidate A, Ghaleb A, Chtita S, Aarjane M, Ousaa A, Maghat H, Sbai A, Choukrad M, Bouachrine M, Lakhlifi T: Identification of a novel dual-target scaffold for 3CLpro and RdRp proteins of SARS-CoV-2 using 3D-similarity search, molecular docking, molecular dynamics and ADMET evaluation. J Biomol Struct Dyn 2020:1-14.